Galera Therapeutics Statistics
Total Valuation
GRTX has a market cap or net worth of 1.70 million. The enterprise value is 150.11 million.
| Market Cap | 1.70M |
| Enterprise Value | 150.11M |
Important Dates
The last earnings date was Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
GRTX has 75.46 million shares outstanding. The number of shares has increased by 46.90% in one year.
| Current Share Class | 75.46M |
| Shares Outstanding | 75.46M |
| Shares Change (YoY) | +46.90% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 29.27% |
| Owned by Institutions (%) | 6.53% |
| Float | 44.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -0.01 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -11.39 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.14
| Current Ratio | 17.14 |
| Quick Ratio | 15.07 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -47.17% |
| Return on Invested Capital (ROIC) | -53.14% |
| Return on Capital Employed (ROCE) | -148.48% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -4.39M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -203,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.31% in the last 52 weeks. The beta is 1.91, so GRTX's price volatility has been higher than the market average.
| Beta (5Y) | 1.91 |
| 52-Week Price Change | -68.31% |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 0.03 |
| Relative Strength Index (RSI) | 42.32 |
| Average Volume (20 Days) | 87,161 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.12 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.47M |
| Pretax Income | -13.38M |
| Net Income | -13.18M |
| EBITDA | -8.45M |
| EBIT | -8.47M |
| Earnings Per Share (EPS) | -0.17 |
Balance Sheet
The company has 5.23 million in cash and 151.05 million in debt, giving a net cash position of -145.82 million or -1.93 per share.
| Cash & Cash Equivalents | 5.23M |
| Total Debt | 151.05M |
| Net Cash | -145.82M |
| Net Cash Per Share | -1.93 |
| Equity (Book Value) | -145.35M |
| Book Value Per Share | -1.96 |
| Working Capital | 5.60M |
Cash Flow
| Operating Cash Flow | -8.33M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GRTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -46.90% |
| Shareholder Yield | n/a |
| Earnings Yield | -776.19% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |